Logo image of AXGT

Axovant Sciences Ltd (AXGT) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:AXGT -

2.1
-0.05 (-2.33%)
Last: 11/12/2020, 8:00:01 PM
2.1
0 (0%)
After Hours: 11/12/2020, 8:00:01 PM

AXGT Key Statistics, Chart & Performance

Key Statistics
Market Cap99.22M
Revenue(TTM)N/A
Net Income(TTM)-53.16M
Shares47.25M
Float29.49M
52 Week High6.12
52 Week Low1.41
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.97
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


AXGT short term performance overview.The bars show the price performance of AXGT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40

AXGT long term performance overview.The bars show the price performance of AXGT in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of AXGT is 2.1 null. In the past month the price decreased by -38.95%. In the past year, price decreased by -55.32%.

Axovant Sciences Ltd / AXGT Daily stock chart

About AXGT

Company Profile

Axovant Sciences Ltd. is a biopharmaceutical company which focuses on the acquisition, development and commercialization of therapeutics for the treatment of neurodegenerative disorders. Its product candidate includes RVT-101 which is in different clinical trial for the treatment of Alzheimer's disease and other forms of dementia. Axovant Sciences Ltd. is based in Hamilton, Bermuda.

Company Info

Axovant Sciences Ltd

11-12 ST. JAMES`S SQUARE SUITE 1 3RD FLOOR

LONDON X0 10036

CEO: Pavan Cheruvu

Phone: 833-296-8268

Axovant Sciences Ltd / AXGT FAQ

What does Axovant Sciences Ltd do?

Axovant Sciences Ltd. is a biopharmaceutical company which focuses on the acquisition, development and commercialization of therapeutics for the treatment of neurodegenerative disorders. Its product candidate includes RVT-101 which is in different clinical trial for the treatment of Alzheimer's disease and other forms of dementia. Axovant Sciences Ltd. is based in Hamilton, Bermuda.


Can you provide the latest stock price for Axovant Sciences Ltd?

The current stock price of AXGT is 2.1 null. The price decreased by -2.33% in the last trading session.


What is the dividend status of Axovant Sciences Ltd?

AXGT does not pay a dividend.


What is the ChartMill rating of Axovant Sciences Ltd stock?

AXGT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Would investing in Axovant Sciences Ltd be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AXGT.


AXGT Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

AXGT Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to AXGT. AXGT has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AXGT Financial Highlights

Over the last trailing twelve months AXGT reported a non-GAAP Earnings per Share(EPS) of -1.9699999999999998. The EPS increased by 67.6% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -74.84%
ROE N/A
Debt/Equity 0.11
Chartmill High Growth Momentum
EPS Q2Q%83.74%
Sales Q2Q%N/A
EPS 1Y (TTM)67.6%
Revenue 1Y (TTM)N/A

AXGT Forecast & Estimates


Analysts
Analysts92
Price TargetN/A
EPS Next Y63.48%
Revenue Next YearN/A

AXGT Ownership

Ownership
Inst Owners0%
Ins Owners39.32%
Short Float %N/A
Short RatioN/A